“BC’s Opioid Crisis: Major Turn as Lawsuit Certified”
British Columbia has certified a class-action lawsuit against pharmaceutical companies involved in the opioid crisis, potentially setting a precedent for other provinces.
British Columbia has certified a class-action lawsuit against pharmaceutical companies involved in the opioid crisis, potentially setting a precedent for other provinces.
British Columbia announces a class action lawsuit against opioid companies, addressing the severe burden of the opioid crisis in Canada.
Shuswap Band in BC takes proactive step to combat opioid crisis by taking over child and family services, offering culturally sensitive support to affected families. A powerful model of self-governance amidst the crisis. #opioidcrisis #selfdetermination
British Columbia is taking over 40 pharmaceutical companies to court, blaming them for their role in worsening the opioid crisis.
The opioid crisis in Canada is a deeply intertwined issue, but the development of non-opioid painkillers marks an important milestone in combating it.
The opioid crisis has divided victims over a $10 billion settlement plan with OxyContin maker Purdue Pharma, offering both hope and betrayal.
The Canadian government has implemented a policy change to provide better support for those battling addiction amidst the ongoing opioid crisis.
The Canadian opioid crisis is being highlighted through storytelling by the Binesiwag collective to shed light on the issue and build empathy.
The Canadian opioid crisis has escalated with increasing fatal overdoses and social consequences, prompting calls for better responses and an ongoing class action lawsuit.
“The Canadian Opioid Crisis: FSIN calls for removal of cap on settlement claims to address the devastating effects of opioid abuse.”